GB8907468D0 - Vaccinia vectors,vaccinia genes and expression products thereof - Google Patents

Vaccinia vectors,vaccinia genes and expression products thereof

Info

Publication number
GB8907468D0
GB8907468D0 GB898907468A GB8907468A GB8907468D0 GB 8907468 D0 GB8907468 D0 GB 8907468D0 GB 898907468 A GB898907468 A GB 898907468A GB 8907468 A GB8907468 A GB 8907468A GB 8907468 D0 GB8907468 D0 GB 8907468D0
Authority
GB
United Kingdom
Prior art keywords
vaccinia
expression products
genes
vectors
vaccinia vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898907468A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SMITH GEOFFREY L
Original Assignee
SMITH GEOFFREY L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SMITH GEOFFREY L filed Critical SMITH GEOFFREY L
Priority to GB898907468A priority Critical patent/GB8907468D0/en
Publication of GB8907468D0 publication Critical patent/GB8907468D0/en
Priority to CA002033200A priority patent/CA2033200A1/en
Priority to EP90905571A priority patent/EP0465539A1/en
Priority to PCT/GB1990/000493 priority patent/WO1990012101A1/en
Priority to JP2505342A priority patent/JPH04504357A/en
Priority to AU53509/90A priority patent/AU5350990A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB898907468A 1989-04-03 1989-04-03 Vaccinia vectors,vaccinia genes and expression products thereof Pending GB8907468D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB898907468A GB8907468D0 (en) 1989-04-03 1989-04-03 Vaccinia vectors,vaccinia genes and expression products thereof
CA002033200A CA2033200A1 (en) 1989-04-03 1990-04-03 Vaccinia vectors, vaccinia genes and expression products thereof
EP90905571A EP0465539A1 (en) 1989-04-03 1990-04-03 Vaccinia vectors, vaccinia genes and expression products thereof
PCT/GB1990/000493 WO1990012101A1 (en) 1989-04-03 1990-04-03 Vaccinia vectors, vaccinia genes and expression products thereof
JP2505342A JPH04504357A (en) 1989-04-03 1990-04-03 Vaccinia vector, vaccinia gene and its expression product
AU53509/90A AU5350990A (en) 1989-04-03 1990-04-03 Vaccinia vectors, vaccinia genes and expression products thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898907468A GB8907468D0 (en) 1989-04-03 1989-04-03 Vaccinia vectors,vaccinia genes and expression products thereof

Publications (1)

Publication Number Publication Date
GB8907468D0 true GB8907468D0 (en) 1989-05-17

Family

ID=10654377

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898907468A Pending GB8907468D0 (en) 1989-04-03 1989-04-03 Vaccinia vectors,vaccinia genes and expression products thereof

Country Status (6)

Country Link
EP (1) EP0465539A1 (en)
JP (1) JPH04504357A (en)
AU (1) AU5350990A (en)
CA (1) CA2033200A1 (en)
GB (1) GB8907468D0 (en)
WO (1) WO1990012101A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6309647B1 (en) 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
AU699903B2 (en) * 1990-11-20 1998-12-17 Virogenetics Corporation Measles virus recombinant poxvirus vaccine
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
ATE247163T1 (en) * 1991-03-07 2003-08-15 Virogenetics Corp GENETICALLY PRODUCED STRAIN FOR VACCINES
US5766598A (en) * 1991-03-07 1998-06-16 Virogenetics Corporation Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products
JP3504659B2 (en) * 1991-06-14 2004-03-08 ヴァイロジェネティクス コーポレイション Immunodeficiency virus recombinant poxvirus vaccine
EP0758397B1 (en) * 1994-04-29 2005-06-22 Baxter Healthcare S.A. Recombinant poxviruses with foreign polynucleotides in essential regions
US5858705A (en) 1995-06-05 1999-01-12 Human Genome Sciences, Inc. Polynucleotides encoding human DNA ligase III and methods of using these polynucleotides
JP4719855B2 (en) * 2003-12-05 2011-07-06 国立大学法人北海道大学 Highly safe pressure ulcer vaccine virus and vaccinia virus vector

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0695935B2 (en) * 1986-07-31 1994-11-30 東燃株式会社 Vaccinia virus strain

Also Published As

Publication number Publication date
AU5350990A (en) 1990-11-05
JPH04504357A (en) 1992-08-06
CA2033200A1 (en) 1990-10-04
WO1990012101A1 (en) 1990-10-18
EP0465539A1 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
GB9023352D0 (en) Vaccinia vectors,vaccinia genes and expression products thereof
GB8907468D0 (en) Vaccinia vectors,vaccinia genes and expression products thereof
GB2226954B (en) Hairdryer
AU108041S (en) Epilator
GB2230184B (en) Hair styling implement
ZA889251B (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
GB9204780D0 (en) Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods
EP0437516A4 (en) H. saimiri-htlv-x region vector
GB2232589B (en) Hairdryer
ZA895454B (en) 2,2-dihalogenocy-clopropyl-hydroxy-ethyltriazoles
CS263290A2 (en) Hair chignon
IE883270L (en) Dna expression vectors
GB8909855D0 (en) Expression vector
AU110731S (en) Hairdryer
ZA891059B (en) 1-aminomethyl-3-(2,4-difluoro-3-chlorophenyl)-4-cyano-pyrroles
IE883705L (en) Hair styling products
IE890946L (en) 2,6-methano-1,3-benzodiazocines and intermediates thereof
AU4881090A (en) Personal anti-assault garments
IE893219L (en) H.saimiri-htlv-x region vector
EP0430556A3 (en) (1-akylsubstituted) and 1,1-dialkylsubstituted) carbacephalosporins
GB8919090D0 (en) Cosmetics product
IE892053L (en) 1,4-dihydropyridine-threonines and intermediates.
CS382889A1 (en) 8,10-disubstituted 6,8-dimethylergolines
IE891279L (en) 3,4-dihydroxy-2-pyrrolidinones
IE891569L (en) 2, 6-diaminopyridines